Pandemic influenza A (H1N1) vaccination in The Netherlands: Parental reasoning underlying child vaccination choices

Bults, Marloes; Beaujean, Desirée; Richardus, Jan Hendrik; Steenbergen, Jim E. van; Voeten, Hélène

doi:10.1016/j.vaccine.2011.06.075

Cited by 53 publications

(65 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most frequent concern cited across studies was the opinion that these vaccines could have dangerous adverse reactions [27][28][29][30][31][77][78][79][81][82][83][84][85][86][87][88][89][90]92,[94][95][96][97][98][99][100][101][102][103]. This was often explained by study participants as a perception that these new vaccines were developed too quickly [80,100], resulting in insufficient testing and evidence [31,80,85,86,93,94,98,100,102] and information about long term adverse reactions [82,83,93,95,96]. Studies reported that concerns about inadequate testing also resulted in perceptions of low vaccine effectiveness [32,79,…”

Section: Pandemic Influenza Vaccinesmentioning

confidence: 99%

“…This was often explained by study participants as a perception that these new vaccines were developed too quickly [80,100], resulting in insufficient testing and evidence [31,80,85,86,93,94,98,100,102] and information about long term adverse reactions [82,83,93,95,96]. Studies reported that concerns about inadequate testing also resulted in perceptions of low vaccine effectiveness [32,79,81,86,89,96,98].…”

Section: Pandemic Influenza Vaccinesmentioning

confidence: 99%

“…Other studies discussed participants being influenced by negative media reports [82,86] and contradictory messages [98] about vaccines; while some believed the media overstated the seriousness of AH1N1 [103]. Mistrust was reported towards vaccines [100,103], national and international health authorities [86], and pharmaceutical companies [86].…”

Section: Pandemic Influenza Vaccinesmentioning

confidence: 99%

See 2 more Smart Citations

The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations

Karafillakis

Larson

2017

Vaccine

250

206

View full text Add to dashboard Cite

Findings: A total of 145 articles were selected, most of which were conducted in the UK, the Netherlands and France and studied seasonal influenza, HPV and pandemic influenza vaccination. Across all countries and vaccines, the primary area of concern was vaccine safety, followed by perceptions of low likelihood of contracting vaccine-preventable diseases (VPDs), perceived low severity of VPDs, beliefs that vaccines do not work, and overall lack of information. Concerns were found to be vaccine-, country-and populationspecific. Conclusion: In addition to identifying concerns about vaccination in Europe, this study confirmed the notion that individuals have many safety concerns about vaccination and often believe that the risks of vaccination outweigh their benefits. More research needs to be conducted to explore the impact of different types of communication strategies, which would frame the benefits of vaccination as well as risks of not vaccinating. Strategies to better inform public perceptions of vaccines should include the provision of unbiased, comprehensive information tailored to population information needs, and delivered using multiple and new communication technologies such as social media.

show abstract

Section: Pandemic Influenza Vaccinesmentioning

confidence: 99%

Section: Pandemic Influenza Vaccinesmentioning

confidence: 99%

Section: Pandemic Influenza Vaccinesmentioning

confidence: 99%

See 1 more Smart Citation

The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations

Karafillakis

Larson

2017

Vaccine

250

206

View full text Add to dashboard Cite

show abstract

“…Many parents are concerned about side effects, feel that their child has a low risk of disease, or feel that the vaccine causes disease [73]. Other parents are not interested after soliciting advice from their social network [74]. For patients with chronic illness, one of the strongest predictors for vaccination is physician recommendation [75][76][77][78].…”

Section: Vaccine Refusalmentioning

confidence: 99%

Protecting Pediatric Oncology Patients From Influenza

et al. 2013

View full text Add to dashboard Cite

Influenza is a common respiratory pathogen. Its severity can be unpredictable, but people with chronic illness are at increased risk of severe infection, complications, and death from influenza. This review examines evidence to support various strategies to protect pediatric oncology patients from influenza-related morbidity. Influenza vaccination should be considered standard. Additional evidence-supported measures include antiviral treatment, antiviral prophylaxis, cohorting of patients, and hospital infection control measures. Data from other high-risk populations support the vaccination of family members, double-dose or high-dose vaccination, and the use of barrier methods. These measures have the potential to optimize patient outcomes because there will be fewer treatment interruptions for acute illness. These strategies can also protect patients from prolonged hospitalizations and morbidity related to influenza. The Oncologist 2013;18:204 -211 Implications for Practice: Pediatric oncology patients can have very severe infections with the influenza virus. Their vulnerability is due to chronic illness and immune suppression. Simple strategies, such as ensuring vaccination, infection control measures, and education regarding personal protection can protect this population that is susceptible to severe influenza.

show abstract

“…This was shown during the pandemic influenza outbreak in 2009 in The Netherlands. The internet was used as an information source by 56% of the acceptors of H1N1 influenza vaccine and by 75% of decliners (Bults et al, 2011). This is another reason why it is important to be updated on the beliefs and attitudes concerning vaccination.…”

Section: Introductionmentioning

confidence: 99%